Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Jul;9(3):337-44.
doi: 10.2353/jmoldx.2007.060155.

The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations

Affiliations
Case Reports

The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations

Michaël Boudewijns et al. J Mol Diagn. 2007 Jul.

Abstract

Clonality is a frequently exploited characteristic of lymphoid malignancies. However, in the natural killer (NK) cell subset of large granular lymphocyte proliferations, clonality is difficult to prove because of the lack of specific genetic markers, such as immunoglobulin or T-cell receptor gene rearrangements. The human androgen receptor (HUMARA) assay, a polymerase chain reaction-based X-chromosome inactivation assay, is a potential diagnostic tool in these disorders. Although there is much experience with X-chromosome inactivation assays in myeloid proliferations, these assays have found only very limited application in clonality assessment of NK cell proliferations. We applied the HUMARA assay in laboratory diagnostics for detection of clonality in NK cell proliferations. We describe its test performance and report three cases in which clonality of NK cell populations was investigated by use of this assay. Our results demonstrate the usefulness of the HUMARA assay in the diagnostic workup of NK cell proliferations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Result of the HUMARA assay for patient in case 2. Results are representative for the other cases. Calculations of the ratios are presented in Table 1.

References

    1. Lamy T, Loughran TP., Jr Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999;13:230–240. - PubMed
    1. Loughran TP., Jr Clonal diseases of large granular lymphocytes. Blood. 1993;82:1–14. - PubMed
    1. Langerak AW, Sandberg Y, van Dongen JJ. Spectrum of T-large granular lymphocyte lymphoproliferations: ranging from expanded activated effector T cells to T-cell leukaemia. Br J Haematol. 2003;123:561–562. - PubMed
    1. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP., Jr The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;89:256–260. - PubMed
    1. Busque L, Gilliland DG. X-inactivation analysis in the 1990s: promise and potential problems. Leukemia. 1998;12:128–135. - PubMed